These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16915388)

  • 1. An age-structured epidemic model of rotavirus with vaccination.
    Shim E; Feng Z; Martcheva M; Castillo-Chavez C
    J Math Biol; 2006 Oct; 53(4):719-46. PubMed ID: 16915388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The narrow road to the indigenous rotavirus vaccine.
    Das BK
    Indian J Med Microbiol; 2015; 33(2):203-4. PubMed ID: 25865968
    [No Abstract]   [Full Text] [Related]  

  • 3. A mathematical model of the indirect effects of rotavirus vaccination.
    Van Effelterre T; Soriano-Gabarró M; Debrus S; Claire Newbern E; Gray J
    Epidemiol Infect; 2010 Jun; 138(6):884-97. PubMed ID: 20028612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales.
    Atchison C; Lopman B; Edmunds WJ
    Vaccine; 2010 Apr; 28(18):3118-26. PubMed ID: 20197142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
    Shim E; Galvani AP
    Vaccine; 2009 Jun; 27(30):4025-30. PubMed ID: 19389452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global impact of rotavirus vaccines.
    Tate JE; Patel MM; Steele AD; Gentsch JR; Payne DC; Cortese MM; Nakagomi O; Cunliffe NA; Jiang B; Neuzil KM; de Oliveira LH; Glass RI; Parashar UD
    Expert Rev Vaccines; 2010 Apr; 9(4):395-407. PubMed ID: 20370550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and Economic Impact of Monovalent and Pentavalent Rotavirus Vaccines in Low and Middle Income Countries: A Cost-effectiveness Modeling Analysis.
    Paternina-Caicedo A; De la Hoz-Restrepo F; Alvis-Guzmán N
    Pediatr Infect Dis J; 2015 Jul; 34(7):e176-84. PubMed ID: 25923424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus vaccines--an update.
    Dennehy PH
    Vaccine; 2007 Apr; 25(16):3137-41. PubMed ID: 17321017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rotavirus vaccination in Europe in 2010].
    Grimprel E
    Bull Acad Natl Med; 2010 Nov; 194(8):1451-62; discussion 1462-4. PubMed ID: 22046709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.
    Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP
    Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan.
    de Blasio BF; Kasymbekova K; Flem E
    Vaccine; 2010 Nov; 28(50):7923-32. PubMed ID: 20933563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children.
    Anderson EJ; Rupp A; Shulman ST; Wang D; Zheng X; Noskin GA
    Pediatrics; 2011 Feb; 127(2):e264-70. PubMed ID: 21262887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccines at the threshold of implementation in India.
    Tate JE; Arora R; Kang G; Parashar UD
    Natl Med J India; 2014; 27(5):245-8. PubMed ID: 26037421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defeating rotavirus? The global recommendation for rotavirus vaccination.
    Danchin MH; Bines JE
    N Engl J Med; 2009 Nov; 361(20):1919-21. PubMed ID: 19907040
    [No Abstract]   [Full Text] [Related]  

  • 16. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology. Does viral diversity matter?
    Medley GF; Nokes DJ
    Science; 2009 Jul; 325(5938):274-5. PubMed ID: 19608903
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine.
    Grant L; Watt J; Moulton L; Weatherholtz R; Reid R; Santosham M; O'Brien K
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):635-40. PubMed ID: 23343932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
    Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
    Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
    Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.